Point-Counterpoint: Should MRSA nares testing be used as a tool for vancomycin de-escalation outside of pneumonia?

Dan Ilges, Drew T. Dickinson, Jennifer M. Bosquez, Erin H. Graf

Open source

DOI
10.1128/jcm.01309-25
Published
2026-05-13
Container
Journal of Clinical Microbiology
Publisher
American Society for Microbiology
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1128/jcm.01309-25,
  title = {Point-Counterpoint: Should MRSA nares testing be used as a tool for vancomycin de-escalation outside of pneumonia?},
  author = {Dan Ilges and Drew T. Dickinson and Jennifer M. Bosquez and Erin H. Graf},
  year = {2026},
  journal = {Journal of Clinical Microbiology},
  doi = {10.1128/jcm.01309-25},
  url = {https://doi.org/10.1128/jcm.01309-25}
}

RIS

TY  - JOUR
TI  - Point-Counterpoint: Should MRSA nares testing be used as a tool for vancomycin de-escalation outside of pneumonia?
AU  - Dan Ilges
AU  - Drew T. Dickinson
AU  - Jennifer M. Bosquez
AU  - Erin H. Graf
PY  - 2026
JO  - Journal of Clinical Microbiology
DO  - 10.1128/jcm.01309-25
UR  - https://doi.org/10.1128/jcm.01309-25
ER  - 

APA

Ilges, D., Dickinson, D. T., Bosquez, J. M., & Graf, E. H. (2026). Point-Counterpoint: Should MRSA nares testing be used as a tool for vancomycin de-escalation outside of pneumonia?. Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01309-25

Source records